Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG

Liang, Chengyu; Feng, Pinghui; Ku, Bonsu; Dotan, Iris; Canaani, Dan; Oh, Byung‐Ha; Jung, Jae U.

doi:10.1038/ncb1426

Cited by 940 publications

(931 citation statements)

References 38 publications

Supporting

Mentioning

894

Contrasting

Unclassified

Order By: Relevance

“…Different binding interactions for the BH3-domain of Beclin-1 bound to Bcl-xL compared with other BH3-domains were also reported (Feng et al, 2007;Oberstein et al, 2007). Moreover, Beclin-1 is bound to many other proteins in addition to Bcl-2 family members (Vps34 (Furuya et al, 2005), UVRAG (Liang et al, 2006;Takahashi et al, 2007), Bif1 (Takahashi et al, 2007) Ambra (Fimia et al, 2007)), which may further obscure the function of the BH3-domain. It is interesting to note that UVRAG was recently reported to modulate the stoichiometry of Beclin-1 binding to Bcl-2/xL (Noble et al, 2008;Samara et al, 2008), but the impact on apoptosis is not known.…”

Section: Discussionmentioning

confidence: 99%

Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function

et al. 2009

View full text Add to dashboard Cite

The binding of Bcl-2 to Beclin-1 reduces Beclin-1's capacity to induce autophagy. Here, we have tested whether the interaction is reciprocated by loss of Bcl-2's anti-apoptotic function. We targeted Bcl-2 to mitochondria or endoplasmic reticulum (ER) and induced apoptosis using several apoptotic stimuli that initiate ER and/or mitochondrial signaling pathways (UV radiation, TNF and cycloheximide, staurosporine, thapsigargin and tunicamycin). When Beclin-1 and Bcl-2 were expressed together in HeLa cells, Beclin-1 (but not Beclin-1 lacking the Bcl-2-binding domain) followed Bcl-2 to the appropriate organelle with complete or near-complete overlap (comprising 60 and 30% of cells, respectively). The interaction between Beclin-1 and Bcl-2 was verified by immunoprecipitation, and a membrane-proximate localization of Beclin-1 was shown by immunoelectron microscopy. Apoptosis was followed by measuring changes in nuclear morphology, caspase-3 activity, poly-ADP-ribose polymerase cleavage or punctation of mRFP-Bax on mitochondria. Binding of Beclin-1 to Bcl-2 did not modify apoptosis irrespective of Bcl-2 concentration, location or apoptotic stimulus. A similar result was obtained in Atg5À/À cells that are autophagy-deficient, arguing against compensation for the loss of protection by Bcl-2 by autophagy-mediated survival induced by Beclin-1. Hence, although Beclin-1 contains a BH3-only motif typical of pro-apoptotic proteins, it is a negligible modulator of Bcl-2's anti-apoptotic function.

show abstract

Section: Discussionmentioning

confidence: 99%

Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function

et al. 2009

View full text Add to dashboard Cite

show abstract

“…Furthermore, the autophagy related gene, Atg5, has been reported to suppress tumor genesis in a mouse xenograft model [27] . More interestingly, the expression of both Beclin 1 and UVRAG has been shown to repress the growth of human cancer cell xenografts [28] . Thus, although the molecular mechanisms are poorly understood, it is reasonable to postulate the importance of autophagy in tumor suppression.…”

Section: Autophagic Flux Defects In Cancermentioning

confidence: 99%

Why should autophagic flux be assessed?

et al. 2013

View full text Add to dashboard Cite

As autophagy is involved in cell growth, survival, development and death, impaired autophagic flux has been linked to a variety of human pathophysiological processes, including neurodegeneration, cancer, myopathy, cardiovascular and immune-mediated disorders. There is a growing need to identify and quantify the status of autophagic flux in different pathological conditions. Given that autophagy is a highly dynamic and complex process that is regulated at multiple steps, it is often assessed accurately. This perspective review article will focus on the autophagic flux defects in different human disorders and update the current methods of monitoring autophagic flux. This knowledge is essential for developing autophagy-related therapeutics for treating the diseases.

show abstract

“…Nucleation of the autophagic vesicle involves a Type III PI3 kinase complex that includes the kinase (Vps34) and Beclin1 (Atg6), which interact through a conserved domain in Beclin 1 (33). This complex contains multiple proteins including another putative tumor suppressor called UVRAG (34) and a protein called Ambra1 (35) , which regulate the activity of the kinase and thus control autophagy induction. Recently it was demonstrated that another protein called Bif-1 binds to UVRAG and that this interaction can also regulate the PI3 kinase activity and induce autophagic vesicle formation (36).…”

Section: Regulation Of Autophagymentioning

confidence: 99%

Apoptosis and autophagy: regulatory connections between two supposedly different processes

2007

View full text Add to dashboard Cite

Apoptosis and autophagy are genetically-regulated, evolutionarily-conserved processes that regulate cell fate. Both apoptosis and autophagy are important in development and normal physiology and in a wide range of diseases. Recent studies show that despite the marked differences between these two processes, their regulation is intimately connected and the same regulators can sometimes control both apoptosis and autophagy. In this review, I discuss some of these findings, which provide possible molecular mechanisms for crosstalk between apoptosis and autophagy and suggest that it may be useful to think of these processes as different facets of the same cell death continuum rather than completely separate processes. KeywordsAutophagy; Apoptosis; Bcl-2, FADD; Atg 5In the early to mid 1990s there was a rapid increase in our understating about the regulation of apoptosis. Fifteen or so years later we are in the midst of a similarly exciting period for understanding autophagy with very rapid growth of publications on the regulation and function of this process (1). Autophagy (the form of autophagy discussed here is macroautophagy, other forms-microautophagy and chaperone-mediated autophagy share the same lysosomal degradation mechanism but differ in the way that material is delivered to the lysosome) is a degradative process involving sequestration of parts of the cytoplasm in double membrane vesicles (autophagic vesicles or autophagosomes) that fuse with lysosomes forming the autophagolysosome. In the autophagolysosome, the cytoplasmic material that was engulfed is hydrolyzed and the resulting amino acids and other macromolecular precursors can be recycled (2-4), see Fig 1 for a schematic of the process. Autophagy is a mechanism by which organelles are removed and is the primary degradation mechanism for long-lived proteins and thus maintains quality control for proteins and organelles. Autophagy is ubiquitous in eukaryotic cells and important in development and in diverse pathophysiological conditions (5)-for example providing protection against neurodegeneration (6,7), infections (8,9) and tumor development (10-13). Cells that are deficient in autophagy also demonstrate enhanced chromosomal instability (14,15), which may be related to the tumorigenesis associated with autophagy deficiency.Autophagy is important in cell death decisions and can protect cells by preventing them from undergoing apoptosis. For example, increased autophagy in nutrient deprived or growth factorwithdrawn cells allows cell survival (16,17) by inhibiting apoptosis. Autophagy also protects cells from various other apoptotic stimuli (18). It is not clear how autophagy stops cells from undergoing apoptosis; one suggested mechanism is the sequestration of damaged mitochondria (18) thus preventing released cytochrome c from being able to form a functional apoptosome NIH Public Access Autophagic cell death (also known as Type II programmed cell death to distinguish it from apoptosis or Type I programmed cell death) (20-22) has been describ...

show abstract

Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG

Cited by 940 publications

References 38 publications

Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function

Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function

Why should autophagic flux be assessed?

Apoptosis and autophagy: regulatory connections between two supposedly different processes

Contact Info

Product

Resources

About